1. GMP aims to ensure quality, safety and efficacy of pharmaceutical products through proper manufacturing and quality control.
2. Key aspects of GMP include facilities and equipment design, sanitation, personnel training, validation processes, documentation systems, and quality control testing.
3. Adhering to GMP guidelines helps manufacturers consistently produce pharmaceuticals that meet specifications and protects patients from defective products.
This document provides an overview of Good Manufacturing Practices (GMP) for pharmaceutical manufacturing. It defines GMP as ensuring products are consistently manufactured and controlled to quality standards for their intended use. The document outlines key aspects of GMP, including facilities and equipment qualification, training, documentation, production and process controls, packaging and labeling, quality testing, and distribution. It explains that GMP is important for producing safe, effective drugs and minimizing risks that cannot be detected through final testing alone. International GMP guidelines from organizations like WHO, FDA, and ICH are also referenced.
1. The document discusses key concepts in pharmaceutical quality including GMP, QA, QC, validation, and contamination control. It provides definitions and explanations of these terms.
2. GMP regulations require manufacturers to ensure product quality and safety. The document outlines 17 key parameters that pharmaceutical companies must follow under GMP.
3. Contamination can occur through particulates, chemicals, or microbes. The document describes major sources of each type of contamination and how they can be controlled.
WHO Good Manufacturing Practice Requirements
Good Manufacturing Practice is the part of quality assurance that ensures that products are consistently manufactured and controlled to the quality standards appropriate to their intended use.
The document discusses Good Manufacturing Practices (GMP), which are regulations and guidelines for manufacturing drug products and medical devices to ensure quality and safety. GMP covers facility and equipment design, sanitization, personnel qualifications, documentation practices, testing of raw and finished materials, production and packaging controls, quality control, and record keeping. Following GMP is important as it aims to guarantee high quality, contamination-free products and helps prevent toxic or ineffective drugs from reaching consumers.
2-Quality-assurance-6th-Sem Quality control and GMPVenkatesh Mantha
The document defines key concepts in quality assurance, quality control, and good manufacturing practices (GMP) for pharmaceuticals. It discusses that quality assurance is a process-oriented approach to ensuring quality, while quality control is a product-oriented approach focused on identifying defects. GMP involves all aspects of pharmaceutical production to minimize risks and ensure quality, safety, and efficacy. It outlines responsibilities for quality control, production, and procedures to verify that medicines meet specifications from raw materials to patient use.
Quality Control and Quality Assurance in Pharmaceuticals.pptxShraddhaJadhav80
This document provides an overview of quality control and quality assurance in the pharmaceutical industry. It discusses key concepts like quality control, quality assurance, good manufacturing practices, good laboratory practices, in-process quality control, regulatory authorities, validation, and quality by design. Quality control ensures pharmaceutical products meet defined standards through testing, while quality assurance monitors the manufacturing process to ensure compliance with regulations and specifications. Together, quality control and quality assurance aim to deliver standardized, contamination-free pharmaceutical products.
Good Manufacture Practices Pharmaceutical technologyafsanamamedova
The document discusses Good Manufacturing Practices (GMP) which are a system for ensuring that products are consistently produced and controlled according to quality standards. It covers GMP guidelines from various organizations, key aspects of GMP like packaging and facilities, and concepts like quality assurance, quality control, documentation practices. GMP is important for minimizing risks in pharmaceutical production and ensuring medicine quality and safety. Adherence to GMP regulations is necessary for pharmaceutical manufacturers and exporters.
This document provides an overview of Good Manufacturing Practices (GMP) for pharmaceutical manufacturing. It defines GMP as ensuring products are consistently manufactured and controlled to quality standards for their intended use. The document outlines key aspects of GMP, including facilities and equipment qualification, training, documentation, production and process controls, packaging and labeling, quality testing, and distribution. It explains that GMP is important for producing safe, effective drugs and minimizing risks that cannot be detected through final testing alone. International GMP guidelines from organizations like WHO, FDA, and ICH are also referenced.
1. The document discusses key concepts in pharmaceutical quality including GMP, QA, QC, validation, and contamination control. It provides definitions and explanations of these terms.
2. GMP regulations require manufacturers to ensure product quality and safety. The document outlines 17 key parameters that pharmaceutical companies must follow under GMP.
3. Contamination can occur through particulates, chemicals, or microbes. The document describes major sources of each type of contamination and how they can be controlled.
WHO Good Manufacturing Practice Requirements
Good Manufacturing Practice is the part of quality assurance that ensures that products are consistently manufactured and controlled to the quality standards appropriate to their intended use.
The document discusses Good Manufacturing Practices (GMP), which are regulations and guidelines for manufacturing drug products and medical devices to ensure quality and safety. GMP covers facility and equipment design, sanitization, personnel qualifications, documentation practices, testing of raw and finished materials, production and packaging controls, quality control, and record keeping. Following GMP is important as it aims to guarantee high quality, contamination-free products and helps prevent toxic or ineffective drugs from reaching consumers.
2-Quality-assurance-6th-Sem Quality control and GMPVenkatesh Mantha
The document defines key concepts in quality assurance, quality control, and good manufacturing practices (GMP) for pharmaceuticals. It discusses that quality assurance is a process-oriented approach to ensuring quality, while quality control is a product-oriented approach focused on identifying defects. GMP involves all aspects of pharmaceutical production to minimize risks and ensure quality, safety, and efficacy. It outlines responsibilities for quality control, production, and procedures to verify that medicines meet specifications from raw materials to patient use.
Quality Control and Quality Assurance in Pharmaceuticals.pptxShraddhaJadhav80
This document provides an overview of quality control and quality assurance in the pharmaceutical industry. It discusses key concepts like quality control, quality assurance, good manufacturing practices, good laboratory practices, in-process quality control, regulatory authorities, validation, and quality by design. Quality control ensures pharmaceutical products meet defined standards through testing, while quality assurance monitors the manufacturing process to ensure compliance with regulations and specifications. Together, quality control and quality assurance aim to deliver standardized, contamination-free pharmaceutical products.
Good Manufacture Practices Pharmaceutical technologyafsanamamedova
The document discusses Good Manufacturing Practices (GMP) which are a system for ensuring that products are consistently produced and controlled according to quality standards. It covers GMP guidelines from various organizations, key aspects of GMP like packaging and facilities, and concepts like quality assurance, quality control, documentation practices. GMP is important for minimizing risks in pharmaceutical production and ensuring medicine quality and safety. Adherence to GMP regulations is necessary for pharmaceutical manufacturers and exporters.
the all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
Quality assurance aims to ensure that pharmaceutical products meet quality standards by building quality into every stage of design, development, and manufacturing. It involves planned and documented activities like process validation, quality audits, and staff training to verify that products satisfy quality requirements. Quality control is the part of GMP concerned with testing and release of materials and products to ensure they meet specifications before release or use. Together, quality assurance and quality control comprise a quality system that helps deliver pharmaceuticals free of contamination and suitable for their intended use.
Unit 9 -Good manufacturing practice.pptxmarakiwmame
This document defines key concepts related to current good manufacturing practices (cGMP), including:
- cGMP ensures products are consistently produced and controlled to quality standards for intended use. It covers facilities, equipment, personnel, and manufacturing procedures.
- The primary goal of cGMP is to prevent errors, contamination, and mix-ups during manufacturing that could lead to unsafe or ineffective products.
- cGMP provides a framework to help ensure products are safe, effective, and high quality. It addresses premises, equipment, documentation, personnel, packaging/labeling, quality control, distribution, validation, and recall procedures.
- Muhammad Mudasser Wali Khan is a Pakistani national with over 20 years of experience in quality assurance and quality control, including 3 years experience in the UAE.
- He has a Master's degree in Zoology with a specialization in microbiology and has worked in quality roles for several pharmaceutical companies in Pakistan and the UAE.
- His responsibilities have included ensuring compliance with GMP, reviewing and approving documentation, conducting audits, and overseeing quality control testing.
GMP Requirements & Drug & Cosmetic Act Provision.pptxEasy Concept
Good Manufacturing Practices (GMP) is that part of quality assurance, which ensures that products are regularly produced and controlled according to the quality standards suitable for their use.
(GMP) comes in Schedule M in D & C Act 1940 and Rules 1945.
GMPs are the requirements that the drug and methods/control /facilities used in their manufacturing, processing and packaging conforms to practice that will assure the safety and efficacy of the product.
Good Laboratory Practice (GLP) guidelines provide standards for laboratory experiments and tests performed to support research, nonclinical studies, and regulatory submissions. The key goals of GLP are to ensure quality, reliability, and integrity of data through adherence to standard operating procedures, trained personnel, appropriate facilities and equipment, records management, and quality control. GLP aims to promote valid and robust research that can be reproduced internationally and supports regulatory review and decision making.
Good Manufacturing Practice (GMP) regulations ensure that pharmaceutical products are consistently produced and controlled according to quality standards. GMP has regulations for facilities, equipment, personnel, sanitation, testing of raw materials and finished products, manufacturing, packaging, quality control, records, and stability. Following GMP procedures guarantees high quality products for consumers by minimizing risks of contamination and ensuring correct labeling and potency. Key aspects of GMP include written procedures, process validation, environmental monitoring, and record keeping. Strict adherence to GMP is important for producing safe, effective medicines.
Good Manufacturing Practice is a set of regulations, codes, and guidelines for the manufacture of drug substances and drug products, medical devices, in vivo and in vitro diagnostic products, and foods.
Quality control involves sampling, testing, and ensuring products meet specifications before release. It is focused on identifying defects in finished products. Key responsibilities include testing raw materials, conducting in-process testing, and approving or rejecting starting materials, packaging, intermediates, and finished products. Quality control aims to fulfill quality requirements and ensure only products passing tests are released.
This document provides an overview of Good Manufacturing Practices (GMP) for pharmaceutical manufacturing. It defines GMP and explains that GMP aims to ensure consistent production of quality products through established processes and quality control. Key aspects of GMP covered include organization and personnel qualifications, facility and equipment design, material management, production operations, quality control testing, and documentation. Maintaining high standards of hygiene, sanitation, maintenance and training are emphasized. The goals of GMP are to minimize risks like contamination, incorrect dosing, and protect patient safety.
Good manufacturing practices (GMP) are regulations for ensuring that products are consistently produced and controlled according to quality standards. GMP was first established in the 1940s and adopted by the WHO in 1969 to minimize risks like contamination in pharmaceutical production. Key aspects of GMP include establishing qualified personnel and facilities, documenting procedures, validating processes, and implementing quality control, assurance, and management systems. Adherence to GMP regulations assures the identity, strength, purity and quality of drug products.
Indian GMP Certification & WHO GMP CertificationVishal Shelke
Indian GMP Certification & WHO GMP Certification by Mr. Vishal Shelke
https://youtube.com/vishalshelke99
https://instagram.com/vishal_stagram
Sub :- Drug Regulatory Affairs
M.Pharm Sem II
Savitribai Phule Pune University
Mr. Krushnakant K. Wable gave a presentation on current good manufacturing practices (cGMP) under the guidance of Dr. Sonali Mahaparale and Dr. D. Y. Patil. The presentation defined cGMP as regulations enforced by the FDA to ensure proper design, monitoring, and control of manufacturing processes and facilities. It also explained that cGMP helps assure the identity, strength, quality and purity of drug products. The presentation covered key components of cGMP like personnel, premises, equipment, standard operating procedures, raw materials, self inspections, and warehousing. It emphasized that cGMP helps prevent contamination, mix-ups, failures and errors to ensure products meet quality standards.
To compare GMP requirement of India, US and Europe for tablets.Aakashdeep Raval
The document discusses Good Manufacturing Practice (GMP) requirements for tablet manufacturing in India, the US, and Europe. It provides an in-depth overview of key GMP requirements for tablet production in India, covering general facility requirements, warehousing, production areas, ancillary areas, quality control, personnel, manufacturing operations, equipment, documentation, quality assurance, and validation. The guidelines outline aspects of production and testing that impact quality, including clearly defined and controlled manufacturing processes, change control, training, facilities, equipment, and documentation.
The document discusses quality assurance activities in the pharmaceutical industry. It defines key terms like quality control, quality assurance, calibration, qualification and validation. It explains the importance of complying with Good Manufacturing Practices (GMP) to ensure product quality and safety. GMP guidelines require validating processes, maintaining facilities and equipment, training staff, and performing regular audits and quality checks. The document compares techniques like cleaning, sanitization, sterilization and disinfection. It also outlines the differences between calibration, qualification and validation activities.
1. The document discusses the key differences between quality assurance (QA) and quality control (QC). QA focuses on processes and aims to prevent defects, while QC focuses on products and aims to identify defects.
2. It also provides an overview of Good Manufacturing Practices (GMP), which ensure products are consistently produced according to quality standards. GMP covers all aspects of production from materials to equipment to personnel.
3. The main GMP principles are that manufacturing processes are clearly defined and validated, adequate resources are provided, instructions are written clearly, procedures are followed correctly, and comprehensive records are kept.
GMP regulations provide minimum standards for pharmaceutical manufacturing to ensure consistent high quality, safety, and efficacy of medicines. Key aspects of GMP include having documented procedures, validated processes, qualified facilities and equipment, trained personnel, cleaning and maintenance programs, quality control testing, and compliance auditing. Following GMP helps manufacturers produce pharmaceuticals that meet marketing authorizations and protects public health.
In this slides you knowing about the current good manufacturing practices, there are playing crusial role in a pharmaceutical industry.
In which slides cover the cgmp objective and location of industry and follow guidelines
Use PyCharm for remote debugging of WSL on a Windo cf5c162d672e4e58b4dde5d797...shadow0702a
This document serves as a comprehensive step-by-step guide on how to effectively use PyCharm for remote debugging of the Windows Subsystem for Linux (WSL) on a local Windows machine. It meticulously outlines several critical steps in the process, starting with the crucial task of enabling permissions, followed by the installation and configuration of WSL.
The guide then proceeds to explain how to set up the SSH service within the WSL environment, an integral part of the process. Alongside this, it also provides detailed instructions on how to modify the inbound rules of the Windows firewall to facilitate the process, ensuring that there are no connectivity issues that could potentially hinder the debugging process.
The document further emphasizes on the importance of checking the connection between the Windows and WSL environments, providing instructions on how to ensure that the connection is optimal and ready for remote debugging.
It also offers an in-depth guide on how to configure the WSL interpreter and files within the PyCharm environment. This is essential for ensuring that the debugging process is set up correctly and that the program can be run effectively within the WSL terminal.
Additionally, the document provides guidance on how to set up breakpoints for debugging, a fundamental aspect of the debugging process which allows the developer to stop the execution of their code at certain points and inspect their program at those stages.
Finally, the document concludes by providing a link to a reference blog. This blog offers additional information and guidance on configuring the remote Python interpreter in PyCharm, providing the reader with a well-rounded understanding of the process.
Redefining brain tumor segmentation: a cutting-edge convolutional neural netw...IJECEIAES
Medical image analysis has witnessed significant advancements with deep learning techniques. In the domain of brain tumor segmentation, the ability to
precisely delineate tumor boundaries from magnetic resonance imaging (MRI)
scans holds profound implications for diagnosis. This study presents an ensemble convolutional neural network (CNN) with transfer learning, integrating
the state-of-the-art Deeplabv3+ architecture with the ResNet18 backbone. The
model is rigorously trained and evaluated, exhibiting remarkable performance
metrics, including an impressive global accuracy of 99.286%, a high-class accuracy of 82.191%, a mean intersection over union (IoU) of 79.900%, a weighted
IoU of 98.620%, and a Boundary F1 (BF) score of 83.303%. Notably, a detailed comparative analysis with existing methods showcases the superiority of
our proposed model. These findings underscore the model’s competence in precise brain tumor localization, underscoring its potential to revolutionize medical
image analysis and enhance healthcare outcomes. This research paves the way
for future exploration and optimization of advanced CNN models in medical
imaging, emphasizing addressing false positives and resource efficiency.
the all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
Quality assurance aims to ensure that pharmaceutical products meet quality standards by building quality into every stage of design, development, and manufacturing. It involves planned and documented activities like process validation, quality audits, and staff training to verify that products satisfy quality requirements. Quality control is the part of GMP concerned with testing and release of materials and products to ensure they meet specifications before release or use. Together, quality assurance and quality control comprise a quality system that helps deliver pharmaceuticals free of contamination and suitable for their intended use.
Unit 9 -Good manufacturing practice.pptxmarakiwmame
This document defines key concepts related to current good manufacturing practices (cGMP), including:
- cGMP ensures products are consistently produced and controlled to quality standards for intended use. It covers facilities, equipment, personnel, and manufacturing procedures.
- The primary goal of cGMP is to prevent errors, contamination, and mix-ups during manufacturing that could lead to unsafe or ineffective products.
- cGMP provides a framework to help ensure products are safe, effective, and high quality. It addresses premises, equipment, documentation, personnel, packaging/labeling, quality control, distribution, validation, and recall procedures.
- Muhammad Mudasser Wali Khan is a Pakistani national with over 20 years of experience in quality assurance and quality control, including 3 years experience in the UAE.
- He has a Master's degree in Zoology with a specialization in microbiology and has worked in quality roles for several pharmaceutical companies in Pakistan and the UAE.
- His responsibilities have included ensuring compliance with GMP, reviewing and approving documentation, conducting audits, and overseeing quality control testing.
GMP Requirements & Drug & Cosmetic Act Provision.pptxEasy Concept
Good Manufacturing Practices (GMP) is that part of quality assurance, which ensures that products are regularly produced and controlled according to the quality standards suitable for their use.
(GMP) comes in Schedule M in D & C Act 1940 and Rules 1945.
GMPs are the requirements that the drug and methods/control /facilities used in their manufacturing, processing and packaging conforms to practice that will assure the safety and efficacy of the product.
Good Laboratory Practice (GLP) guidelines provide standards for laboratory experiments and tests performed to support research, nonclinical studies, and regulatory submissions. The key goals of GLP are to ensure quality, reliability, and integrity of data through adherence to standard operating procedures, trained personnel, appropriate facilities and equipment, records management, and quality control. GLP aims to promote valid and robust research that can be reproduced internationally and supports regulatory review and decision making.
Good Manufacturing Practice (GMP) regulations ensure that pharmaceutical products are consistently produced and controlled according to quality standards. GMP has regulations for facilities, equipment, personnel, sanitation, testing of raw materials and finished products, manufacturing, packaging, quality control, records, and stability. Following GMP procedures guarantees high quality products for consumers by minimizing risks of contamination and ensuring correct labeling and potency. Key aspects of GMP include written procedures, process validation, environmental monitoring, and record keeping. Strict adherence to GMP is important for producing safe, effective medicines.
Good Manufacturing Practice is a set of regulations, codes, and guidelines for the manufacture of drug substances and drug products, medical devices, in vivo and in vitro diagnostic products, and foods.
Quality control involves sampling, testing, and ensuring products meet specifications before release. It is focused on identifying defects in finished products. Key responsibilities include testing raw materials, conducting in-process testing, and approving or rejecting starting materials, packaging, intermediates, and finished products. Quality control aims to fulfill quality requirements and ensure only products passing tests are released.
This document provides an overview of Good Manufacturing Practices (GMP) for pharmaceutical manufacturing. It defines GMP and explains that GMP aims to ensure consistent production of quality products through established processes and quality control. Key aspects of GMP covered include organization and personnel qualifications, facility and equipment design, material management, production operations, quality control testing, and documentation. Maintaining high standards of hygiene, sanitation, maintenance and training are emphasized. The goals of GMP are to minimize risks like contamination, incorrect dosing, and protect patient safety.
Good manufacturing practices (GMP) are regulations for ensuring that products are consistently produced and controlled according to quality standards. GMP was first established in the 1940s and adopted by the WHO in 1969 to minimize risks like contamination in pharmaceutical production. Key aspects of GMP include establishing qualified personnel and facilities, documenting procedures, validating processes, and implementing quality control, assurance, and management systems. Adherence to GMP regulations assures the identity, strength, purity and quality of drug products.
Indian GMP Certification & WHO GMP CertificationVishal Shelke
Indian GMP Certification & WHO GMP Certification by Mr. Vishal Shelke
https://youtube.com/vishalshelke99
https://instagram.com/vishal_stagram
Sub :- Drug Regulatory Affairs
M.Pharm Sem II
Savitribai Phule Pune University
Mr. Krushnakant K. Wable gave a presentation on current good manufacturing practices (cGMP) under the guidance of Dr. Sonali Mahaparale and Dr. D. Y. Patil. The presentation defined cGMP as regulations enforced by the FDA to ensure proper design, monitoring, and control of manufacturing processes and facilities. It also explained that cGMP helps assure the identity, strength, quality and purity of drug products. The presentation covered key components of cGMP like personnel, premises, equipment, standard operating procedures, raw materials, self inspections, and warehousing. It emphasized that cGMP helps prevent contamination, mix-ups, failures and errors to ensure products meet quality standards.
To compare GMP requirement of India, US and Europe for tablets.Aakashdeep Raval
The document discusses Good Manufacturing Practice (GMP) requirements for tablet manufacturing in India, the US, and Europe. It provides an in-depth overview of key GMP requirements for tablet production in India, covering general facility requirements, warehousing, production areas, ancillary areas, quality control, personnel, manufacturing operations, equipment, documentation, quality assurance, and validation. The guidelines outline aspects of production and testing that impact quality, including clearly defined and controlled manufacturing processes, change control, training, facilities, equipment, and documentation.
The document discusses quality assurance activities in the pharmaceutical industry. It defines key terms like quality control, quality assurance, calibration, qualification and validation. It explains the importance of complying with Good Manufacturing Practices (GMP) to ensure product quality and safety. GMP guidelines require validating processes, maintaining facilities and equipment, training staff, and performing regular audits and quality checks. The document compares techniques like cleaning, sanitization, sterilization and disinfection. It also outlines the differences between calibration, qualification and validation activities.
1. The document discusses the key differences between quality assurance (QA) and quality control (QC). QA focuses on processes and aims to prevent defects, while QC focuses on products and aims to identify defects.
2. It also provides an overview of Good Manufacturing Practices (GMP), which ensure products are consistently produced according to quality standards. GMP covers all aspects of production from materials to equipment to personnel.
3. The main GMP principles are that manufacturing processes are clearly defined and validated, adequate resources are provided, instructions are written clearly, procedures are followed correctly, and comprehensive records are kept.
GMP regulations provide minimum standards for pharmaceutical manufacturing to ensure consistent high quality, safety, and efficacy of medicines. Key aspects of GMP include having documented procedures, validated processes, qualified facilities and equipment, trained personnel, cleaning and maintenance programs, quality control testing, and compliance auditing. Following GMP helps manufacturers produce pharmaceuticals that meet marketing authorizations and protects public health.
In this slides you knowing about the current good manufacturing practices, there are playing crusial role in a pharmaceutical industry.
In which slides cover the cgmp objective and location of industry and follow guidelines
Use PyCharm for remote debugging of WSL on a Windo cf5c162d672e4e58b4dde5d797...shadow0702a
This document serves as a comprehensive step-by-step guide on how to effectively use PyCharm for remote debugging of the Windows Subsystem for Linux (WSL) on a local Windows machine. It meticulously outlines several critical steps in the process, starting with the crucial task of enabling permissions, followed by the installation and configuration of WSL.
The guide then proceeds to explain how to set up the SSH service within the WSL environment, an integral part of the process. Alongside this, it also provides detailed instructions on how to modify the inbound rules of the Windows firewall to facilitate the process, ensuring that there are no connectivity issues that could potentially hinder the debugging process.
The document further emphasizes on the importance of checking the connection between the Windows and WSL environments, providing instructions on how to ensure that the connection is optimal and ready for remote debugging.
It also offers an in-depth guide on how to configure the WSL interpreter and files within the PyCharm environment. This is essential for ensuring that the debugging process is set up correctly and that the program can be run effectively within the WSL terminal.
Additionally, the document provides guidance on how to set up breakpoints for debugging, a fundamental aspect of the debugging process which allows the developer to stop the execution of their code at certain points and inspect their program at those stages.
Finally, the document concludes by providing a link to a reference blog. This blog offers additional information and guidance on configuring the remote Python interpreter in PyCharm, providing the reader with a well-rounded understanding of the process.
Redefining brain tumor segmentation: a cutting-edge convolutional neural netw...IJECEIAES
Medical image analysis has witnessed significant advancements with deep learning techniques. In the domain of brain tumor segmentation, the ability to
precisely delineate tumor boundaries from magnetic resonance imaging (MRI)
scans holds profound implications for diagnosis. This study presents an ensemble convolutional neural network (CNN) with transfer learning, integrating
the state-of-the-art Deeplabv3+ architecture with the ResNet18 backbone. The
model is rigorously trained and evaluated, exhibiting remarkable performance
metrics, including an impressive global accuracy of 99.286%, a high-class accuracy of 82.191%, a mean intersection over union (IoU) of 79.900%, a weighted
IoU of 98.620%, and a Boundary F1 (BF) score of 83.303%. Notably, a detailed comparative analysis with existing methods showcases the superiority of
our proposed model. These findings underscore the model’s competence in precise brain tumor localization, underscoring its potential to revolutionize medical
image analysis and enhance healthcare outcomes. This research paves the way
for future exploration and optimization of advanced CNN models in medical
imaging, emphasizing addressing false positives and resource efficiency.
Comparative analysis between traditional aquaponics and reconstructed aquapon...bijceesjournal
The aquaponic system of planting is a method that does not require soil usage. It is a method that only needs water, fish, lava rocks (a substitute for soil), and plants. Aquaponic systems are sustainable and environmentally friendly. Its use not only helps to plant in small spaces but also helps reduce artificial chemical use and minimizes excess water use, as aquaponics consumes 90% less water than soil-based gardening. The study applied a descriptive and experimental design to assess and compare conventional and reconstructed aquaponic methods for reproducing tomatoes. The researchers created an observation checklist to determine the significant factors of the study. The study aims to determine the significant difference between traditional aquaponics and reconstructed aquaponics systems propagating tomatoes in terms of height, weight, girth, and number of fruits. The reconstructed aquaponics system’s higher growth yield results in a much more nourished crop than the traditional aquaponics system. It is superior in its number of fruits, height, weight, and girth measurement. Moreover, the reconstructed aquaponics system is proven to eliminate all the hindrances present in the traditional aquaponics system, which are overcrowding of fish, algae growth, pest problems, contaminated water, and dead fish.
Introduction- e - waste – definition - sources of e-waste– hazardous substances in e-waste - effects of e-waste on environment and human health- need for e-waste management– e-waste handling rules - waste minimization techniques for managing e-waste – recycling of e-waste - disposal treatment methods of e- waste – mechanism of extraction of precious metal from leaching solution-global Scenario of E-waste – E-waste in India- case studies.
Optimizing Gradle Builds - Gradle DPE Tour Berlin 2024Sinan KOZAK
Sinan from the Delivery Hero mobile infrastructure engineering team shares a deep dive into performance acceleration with Gradle build cache optimizations. Sinan shares their journey into solving complex build-cache problems that affect Gradle builds. By understanding the challenges and solutions found in our journey, we aim to demonstrate the possibilities for faster builds. The case study reveals how overlapping outputs and cache misconfigurations led to significant increases in build times, especially as the project scaled up with numerous modules using Paparazzi tests. The journey from diagnosing to defeating cache issues offers invaluable lessons on maintaining cache integrity without sacrificing functionality.
UNLOCKING HEALTHCARE 4.0: NAVIGATING CRITICAL SUCCESS FACTORS FOR EFFECTIVE I...amsjournal
The Fourth Industrial Revolution is transforming industries, including healthcare, by integrating digital,
physical, and biological technologies. This study examines the integration of 4.0 technologies into
healthcare, identifying success factors and challenges through interviews with 70 stakeholders from 33
countries. Healthcare is evolving significantly, with varied objectives across nations aiming to improve
population health. The study explores stakeholders' perceptions on critical success factors, identifying
challenges such as insufficiently trained personnel, organizational silos, and structural barriers to data
exchange. Facilitators for integration include cost reduction initiatives and interoperability policies.
Technologies like IoT, Big Data, AI, Machine Learning, and robotics enhance diagnostics, treatment
precision, and real-time monitoring, reducing errors and optimizing resource utilization. Automation
improves employee satisfaction and patient care, while Blockchain and telemedicine drive cost reductions.
Successful integration requires skilled professionals and supportive policies, promising efficient resource
use, lower error rates, and accelerated processes, leading to optimized global healthcare outcomes.
Embedded machine learning-based road conditions and driving behavior monitoringIJECEIAES
Car accident rates have increased in recent years, resulting in losses in human lives, properties, and other financial costs. An embedded machine learning-based system is developed to address this critical issue. The system can monitor road conditions, detect driving patterns, and identify aggressive driving behaviors. The system is based on neural networks trained on a comprehensive dataset of driving events, driving styles, and road conditions. The system effectively detects potential risks and helps mitigate the frequency and impact of accidents. The primary goal is to ensure the safety of drivers and vehicles. Collecting data involved gathering information on three key road events: normal street and normal drive, speed bumps, circular yellow speed bumps, and three aggressive driving actions: sudden start, sudden stop, and sudden entry. The gathered data is processed and analyzed using a machine learning system designed for limited power and memory devices. The developed system resulted in 91.9% accuracy, 93.6% precision, and 92% recall. The achieved inference time on an Arduino Nano 33 BLE Sense with a 32-bit CPU running at 64 MHz is 34 ms and requires 2.6 kB peak RAM and 139.9 kB program flash memory, making it suitable for resource-constrained embedded systems.
Advanced control scheme of doubly fed induction generator for wind turbine us...IJECEIAES
This paper describes a speed control device for generating electrical energy on an electricity network based on the doubly fed induction generator (DFIG) used for wind power conversion systems. At first, a double-fed induction generator model was constructed. A control law is formulated to govern the flow of energy between the stator of a DFIG and the energy network using three types of controllers: proportional integral (PI), sliding mode controller (SMC) and second order sliding mode controller (SOSMC). Their different results in terms of power reference tracking, reaction to unexpected speed fluctuations, sensitivity to perturbations, and resilience against machine parameter alterations are compared. MATLAB/Simulink was used to conduct the simulations for the preceding study. Multiple simulations have shown very satisfying results, and the investigations demonstrate the efficacy and power-enhancing capabilities of the suggested control system.
1. GMP and Quality Assurance
B Pharm VI Sem (BP 606 T)
By
Dr. Abhishek Pandey
Assistant Professor
School of Studies in Pharmaceutical Sciences, Jiwaji
University, Gwalior
3. 3
According to FDA a drug is defined as adulterated if the
methods used in its manufacture or processing Testing
Packaging Storing
Did not conform to the GMPs
As a result of this, GMPs were first established in June
1963 The concept was born in U.S.A
4. Drugs being a very important component of health
care system need special attention in regard to their
Quality
Safety
efficacy
4
5. Final testing of the product cannot ensure the
quality, safety, efficacy of a product
Therefore the concept of QC evolved
The development of QC resulted in GMPs
5
6. Many Indian drug manufacturers export
pharmaceutical preparations to other member
countries of WHO
Indian drug manufacturers as well as their technical
personnel should be aware of the GMP guidelines
prepared by WHO
These are referred to WHO GMPs
6
7. What is GMP ?
7
GMP is that part of Quality assurance which
ensures that the products are consistently
manufactured and controlled to the Quality
standards appropriate to their intended use
"GMP" - A set of principles and procedures which,
when followed by manufacturers for therapeutic
goods, helps ensure that the products manufactured
will have the required quality.
8. The Govt of India amended the drugs & cosmetics
rules, 1945 on 24th june 1988 and prescribed GMPs
under Schedule M
Schedule M has 2 parts, part 1 and part 2
GMP guidelines come under part1
The Schedule M has been revised and brought
more less to the level of WHO GMP text
8
9. WHO GMP ensures the following:
9
Avoidance of Cross- Contamination
Prevention of Mix-ups
Provide Traceability
Accountability of actions
Responsibility
Product Performance Guarantee
10. India is the world’s second largest producer of APIs,
not only in quantity but also in the variety of
molecules.
Indian API manufacturers have traditionally
complied with US GMP regulations since the
majority of the material produced is for export.
10
11. 11
The current trend in pharmaceutical companies in India
is that they adopt ICH structured guidelines, GMP
regulations, audit topics and legal requirements as per
target country and gear up for the audit.
But necessarily the manufacturer may not follow
Schedule M for facing international audits. The
difference between the GMP standards of the drug
supplying countries and the receiving countries may
therefore result in ambiguities and difficulties relating to
its compliance.
12. Objectives of GMP
12
To produce products conforming to the pre-
determined specifications
To produce products of consistent quality
To minimize contamination
To eliminate errors
13. Good Manufacturing Practices
13
A basic tenet of GMP is that quality cannot be tested
into a batch of product but must be built into each
batch of product during all stages of the
manufacturing process.
It is designed to minimize the risks involved in any
pharmaceutical production that cannot be eliminated
through testing the final product.
14. 14
diminishing the risks inherent in pharmaceutical
production, which may broadly be categorized into
1. unexpected contamination of products
2. incorrect labels on containers
3. insufficient or too much active ingredient
Above all, manufacturers must not place patients
at risk due to inadequate safety, quality or efficacy;
for this reason, risk assessment has come to play
an important role in WHO quality assurance
guidelines.
Aim of GMP
15. Quality assurance
15
Quality assurance is a much wider concept
Covers all matters which individually or collectively
influence the quality of a product
QA= GCPs + GMPs + GLPs
17. QA
Quality Assurance is the sum total of the organised
procedures ensuring that products will be fit for their
intended use.
GMP
GMP is the part of QA that ensures products are
consistently manufactured to a standard appropriate to
their intended use. It is concerned with both
manufacturing and Quality Control procedures.
QC
Quality Control is the part of GMP which is concerned
with sampling, specification and testing and also
organization, documentation and release.
17
18. WHO GUIDELINES
18
The revised text contains 3 parts.
Part I: out lines the general concepts of quality
assurance and salient components of GMP’s.
Part II: outlines on actions to be taken by production
& qc personnel separately for implementing general
principles of quality assurance.
Part III: supporting and supplementary guidelines.
19. ANNEX I: Quality Management in the Drug
Industry -Philosophy & Essential Elements
19
Quality Assurance
Good Manufacturing
Practice Quality
Control
Sanitation & Hygiene
Validation
Complaints
Product recalls
Contract Production &
Analysis
Personnel
Premises
Material
Documentation
20. ANNEX II: Good Practices – Production &
Quality Control
20
Good Practices in Production
Good Practices in Quality Control
21. ANNEX III: Supporting and
Supplementary Guidelines
21
Sterile pharmaceutical Products
Good Manufacturing Practice for Active
Pharmaceutical Ingredients
22. What is done under GMP can
be summarized as follows
22
1. all processes are clearly defined systematically
2. All necessary resources are provided by
Adequately qualified and trained personnel
Adequate premises and equipment
Adequate services
Appropriate materials, containers and labels
Approved procedures and instruments
Suitable storage and transport
Adequate qc facilities
23. 3. Qualification and validation work is performed
4. Procedures and instructions are written in clear
unambiguous language
5. Operators are trained
6. Manufacturing procedures are recorded
7. All production and distribution records are
retained
8. Proper storage and distribution of products
9. Recall of any product batch
10. Complaints about product quality are investigated
23
26. Organization & Personnel
26
1. Responsibilities of quality control unit.
2. Personnel qualifications.
3. Personnel responsibilities.
4. Consultants.
27. Equipment
27
1. Equipment design, size, and location.
2. Equipment construction.
3. Equipment cleaning and maintenance.
4. Automatic, mechanical, and electronic equipment.
5. Filters.
28. Utilities and facilities
28
Design and construction features. Lighting.
Ventilation, air filtration, air heating and cooling.
Plumbing. .
Washing and toilet facilities.
Sanitation.
Maintenance.
Water (of various grades)
Steam
Compressed air
29. 29
Various other gases
Vacuum
Electricity Cooling
systems
Dust control and collection systems
Effluent and waste disposal systems and drainage
Bulk solvent and other bulk liquid supply systems
Lubrication services
30. Sanitation
30
premises shall be cleaned
free from accumulated waste, dust, debris
A validated cleaning procedure shall be maintained.
routine sanitation program and which shall indicate--
(a)Specific areas to be cleaned and cleaning intervals
(b)Cleaning procedure to be followed, including
equipment and materials to be used for cleaning
(c)Personnel assigned for the cleaning operation.
31. Raw materials
31
inventory
maintain records as per Schedule U.
quarantined immediately after receipt
stored under appropriate conditions
batch segregation and stock rotation.
purchased from approved sources .
32. labeled with the following information:
(a)name of the product
(b)Manufacturers name, address, batch number;
(c)status of the contents (e.g. quarantine, under test,
released, approved, rejected)
(d)manufacturing date, expiry date, re-test date.
Only QC passed materials should be released
32
33. Manufacturing operations
33
carried out under the supervision of technical staff
Critical steps shall be performed by trained personnel
under the direct personal supervision of approved
technical staff.
The contents of all vessels and containers shall be
conspicuously labeled
Precautions against mix-up and cross-contamination-
SOPs shall be maintained.
All equipment shall be labeled with their current status.
34. processing of sensitive drugs in isolated production
areas with independent air-handling unit and proper
pressure differential.
Packaging lines shall be adequately segregated.
required levels of temperature, humidity and
cleanliness.
uniforms for manufacturing operations including
packaging.
segregated enclosed areas, secured for recalled
or rejected material
34
36. area of qc lab may be divided into
Chemical
36
Instrumentation
Microbiological
Biological testing.
storage conditions shall be provided for
keeping reference samples.
SOPs for sampling, inspecting and testing of
raw materials,
intermediate
bulk finished products packing materials.
37. Documentation
37
Its aim is to
define the specifications for all materials,
method of manufacture,
to provide an audit trail
designed, prepared, reviewed and controlled, wherever
applicable,
approved, signed and dated by appropriate and
authorized persons.
specify the title, nature and purpose.
38. laid out in an orderly fashion and be easy to
check. clear and legible.
38
regularly reviewed and kept up to date.
alteration made shall be signed and dated. Records and
SOPs shall be retained
Data may be recorded by electronic data processing
systems or other reliable means, but Master Formulae
shall also be available in a hard copy
40. Conclusion
40
The Quality of a drug depends on the Quality of those
producing it
The problem cannot be solved by tighter regulations alone.
Continuous and professional auditing is essential to
overcome the challenge of meeting stringent requirements
of GMP.
GMP is doing the right thing when nobody is watching but it
will reflect in the final product being right.
In matter of GMP, swim with the current and in
matter of Quality stand like a rock!